<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yuan L</submitter><funding>NCATS NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>625-643</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5993829</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(6)</volume><pubmed_abstract>Cellular senescence is a fundamental cell fate playing a significant role throughout the natural aging process. However, the molecular determinants distinguishing senescence from other cell-cycle arrest states such as quiescence and post-mitotic state, and the specified mechanisms underlying cell-fate decisions towards senescence versus cell death in response to cellular stress stimuli remain less understood. Employing multi-omics approaches, we revealed that switching off the specific mitochondrial processing machinery involving the peptidase IMMP2L serves as the foundation of the senescence program, which was also observed during the mammalian aging process. Mechanistically, we demonstrate that IMMP2L processes and thus activates at least two substrates, mitochondrial metabolic enzyme gl</pubmed_abstract><journal>Cell research</journal><pubmed_title>Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death.</pubmed_title><pmcid>PMC5993829</pmcid><funding_grant_id>R01 CA154586</funding_grant_id><funding_grant_id>UL1 TR001117</funding_grant_id><pubmed_authors>Huang</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Tan M</pubmed_authors><pubmed_authors>Yuan L</pubmed_authors><pubmed_authors>Xiang H</pubmed_authors><pubmed_authors>Wang XF</pubmed_authors><pubmed_authors>Thompson JW</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Chen XQ</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>He YH</pubmed_authors><pubmed_authors>Kong QP</pubmed_authors><pubmed_authors>Zhai L</pubmed_authors><pubmed_authors>Qian L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death.</name><description>Cellular senescence is a fundamental cell fate playing a significant role throughout the natural aging process. However, the molecular determinants distinguishing senescence from other cell-cycle arrest states such as quiescence and post-mitotic state, and the specified mechanisms underlying cell-fate decisions towards senescence versus cell death in response to cellular stress stimuli remain less understood. Employing multi-omics approaches, we revealed that switching off the specific mitochondrial processing machinery involving the peptidase IMMP2L serves as the foundation of the senescence program, which was also observed during the mammalian aging process. Mechanistically, we demonstrate that IMMP2L processes and thus activates at least two substrates, mitochondrial metabolic enzyme gl</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jun</publication><modification>2026-04-29T16:19:42.233Z</modification><creation>2019-07-01T13:50:12Z</creation></dates><accession>S-EPMC5993829</accession><cross_references><pubmed>29808012</pubmed><doi>10.1038/s41422-018-0043-5</doi></cross_references></HashMap>